Zentek Announces Management Transition
Zentek (NASDAQ:ZTEK) announced that CEO Greg Fenton's consulting contract will not be extended beyond its expiration date of March 31, 2026. The board of directors has initiated a search for his successor, while the current executive team continues to lead the company in the interim.
Fenton served as CEO for seven years, during which he guided the company's growth and diversification. The board emphasized its commitment to appointing a new CEO who will focus on transitioning Zentek from research and development to commercialization.
Zentek (NASDAQ:ZTEK) ha annunciato che il contratto di consulenza del CEO Greg Fenton non sarà rinnovato oltre la sua scadenza del 31 marzo 2026. Il consiglio di amministrazione ha avviato la ricerca del suo successore, mentre l'attuale team dirigenziale continuerà a guidare l'azienda nel frattempo.
Fenton è stato CEO per sette anni, durante i quali ha guidato la crescita e la diversificazione dell'azienda. Il consiglio ha sottolineato il proprio impegno a nominare un nuovo CEO che si concentrerà sulla transizione di Zentek dalla fase di ricerca e sviluppo a quella di commercializzazione.
Zentek (NASDAQ:ZTEK) anunció que el contrato de consultorÃa del CEO Greg Fenton no será renovado más allá de su fecha de vencimiento el 31 de marzo de 2026. La junta directiva ha iniciado la búsqueda de su sucesor, mientras que el equipo ejecutivo actual continuará liderando la empresa de forma provisional.
Fenton se desempeñó como CEO durante siete años, perÃodo en el cual dirigió el crecimiento y la diversificación de la compañÃa. La junta enfatizó su compromiso de nombrar un nuevo CEO que se enfoque en la transición de Zentek desde la investigación y desarrollo hacia la comercialización.
Zentek (NASDAQ:ZTEK)ëŠ� CEO Greg Fentonì� 컨설íŒ� 계약ì� 2026ë…� 3ì›� 31ì� 만료ì� ì´í›„ 연장ë˜ì§€ ì•Šì„ ê²ƒì´ë¼ê³ 발표했습니다. ì´ì‚¬íšŒëŠ” ê·¸ì˜ í›„ìž„ìž� 찾기ë¥� 시작했으ë©�, 현재 ê²½ì˜ì§„ì€ ê·¸ë™ì•� 회사ë¥� ì´ëŒ ì˜ˆì •ìž…ë‹ˆë‹�.
¹ó±ð²Ô³Ù´Ç²Ôì¶Ä 7ÔÆ„ê°„ CEOë¡� 재ì§í•˜ë©° 회사ì� 성장ê³� 다ê°í™”를 ì´ëŒì—ˆìŠµë‹ˆë‹¤. ì´ì‚¬íšŒëŠ” Zentekê°€ 연구개발 단계ì—서 ìƒì—…í™� 단계ë¡� ì „í™˜í•˜ëŠ” ë� 집중í•� 새로ìš� CEOë¥� 임명하는 ë� ì „ë…í•� 것임ì� 강조했습니다.
Zentek (NASDAQ:ZTEK) a annoncé que le contrat de conseil du PDG Greg Fenton ne sera pas prolongé au-delà de sa date d'expiration, le 31 mars 2026. Le conseil d'administration a lancé la recherche de son successeur, tandis que l'équipe de direction actuelle continuera de diriger l'entreprise en attendant.
Fenton a occupé le poste de PDG pendant sept ans, période durant laquelle il a piloté la croissance et la diversification de l'entreprise. Le conseil a souligné son engagement à nommer un nouveau PDG qui se concentrera sur la transition de Zentek de la recherche et développement vers la commercialisation.
Zentek (NASDAQ:ZTEK) gab bekannt, dass der Beratungsvertrag von CEO Greg Fenton über das Ablaufdatum am 31. März 2026 hinaus nicht verlängert wird. Der Vorstand hat die Suche nach seinem Nachfolger eingeleitet, während das aktuelle Führungsteam das Unternehmen interimistisch weiterführt.
Fenton war sieben Jahre als CEO tätig und leitete in dieser Zeit das Wachstum und die Diversifizierung des Unternehmens. Der Vorstand betonte sein Engagement, einen neuen CEO zu ernennen, der den Übergang von Zentek von Forschung und Entwicklung zur Kommerzialisierung fokussiert.
- Company signals strategic shift towards commercialization phase
- Orderly transition process with advance notice of leadership change
- Uncertainty during CEO transition period
- Loss of experienced leadership with 7-year tenure
GUELPH, ON / / July 11, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company, announces that the board of directors has determined not to extend the consulting contract for Greg Fenton, the Company's Chief Executive Officer and a Director of the Company, when the term expires on March 31, 2026. The Company has begun its search for Mr. Fenton's successor, and, until such successor has been appointed, the Company's current executive team will continue to lead the Company.
"On behalf of the Board, I want to thank Greg for guiding Zentek on its path of growth and diversification over the past seven years, and for his stewardship of the business," said Eric Wallman, Chairman of the board of directors. "The board of directors is committed to ensuring that the new Chief Executive Officer will drive Zentek's transition from research and development to commercialization."
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD�, is shown to significantly increase the bacterial and viral filtration efficiency for surgical masks and aims to do the same with HVAC (heating, ventilation, and air conditioning) filters. Zentek's ZenGUARD� production facility is in Guelph, Ontario.
Zentek, through its wholly owned subsidiary, Triera Biosciences Ltd., has a global exclusive licence to the aptamer-based platform technology developed by McMaster University, which is being jointly developed by Zentek and McMaster for both the diagnostic and therapeutic markets.
For further information:
Ryan Shacklock
Email:[email protected]
306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Zentek Ltd.
View the original on ACCESS Newswire